Treatment of breast cancer
AssigneesMedivation Prostate Therapeutics, Inc., The Regents of the University of Colorado, a body corporate
InventorsAndrew A. Protter, Jennifer Richer, Dawn Cochrane
Life of this patent
Estimating the term…
Abstract
The disclosure describes the use of one or more compounds that fall within the scope of one or more of structural formulae I, II, III, IV, V, or VI for treating triple negative breast Compounds useful for treating breast cancer include those compounds of formulae I, II, III, IV, V, or VI that inhibit proliferation of breast cancer cells and/or lead to the death of breast cancer cells, especially triple negative breast cancer.
Claims23
A method of treating triple negative breast cancer, comprising administering to a patient in need thereof a therapeutically effective amount of a compound or a pharmaceutically acceptable salt of the compound, wherein the compound is selected from the group consisting of
Dependencies are inferred from the claim text.